Provision of Real Time PCR System and Accessories

CPV: Real-time Polymerase Chain Reaction (PCR) equipment

Procedure method

Award procedure without prior publication of a call for competition

Legal basis

CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)

Procurement category

Goods

Notice status

Awarded without competition

Procurement threshold

Unspecified in notice

Regulatory regime

Standard

Commercial structure

Stand-alone contract (no framework)

Competition type

Direct award (no call for competition)

GPA / WTO covered

Yes (GPA)

Recurring procurement

Unspecified in notice

First published

16 Nov 2021, 17:10 GMT

Last source update

16 Nov 2021, 17:10 GMT

Authority reference

LSHTM-2021-34

FTS notice number

2021/S 000-028628

Classification (CPV)

Real-time Polymerase Chain Reaction (PCR) equipment

Delivery area

Gambia (GM)

Official registry OCID

ocds-h6vhtk-02f743 Find a Tender

Why no open competition

The procurement falls outside the scope of application of the directive

Published justification

The MRC Unit the Gambia at LSHTM believes that the items required are unique and proprietary to the supplier with no other equivalent items available on the marketplace. There are also no resellers within the UK or the Gambia.

The BioMark HD System is a unique research and development tool based on proprietary integrated fluidic circuit (IFC) technology that is available solely from Fluidigm. The BioMark HD System is a fully integrated system enabling analysis of gene expression, genotyping, mutant detection, and absolute quantification of nucleic-acid sequences utilizing Digital Array™ and/or Dynamic Array™ IFC technology. The system is solely produced by Fluidigm and the key components are patented and designed to operate as an integrated system. No third-party systems or components are licensed for use on the BioMark HD System or Digital Array and Dynamic Array IFCs. Data generated by the BioMark HD System from experiments run on IFCs can be exported into a variety of common formats for processing in external third party or proprietary software (which include file export mechanisms supporting the common formats).

The Juno™ system is available only from Fluidigm that combines integrated fluidic circuit (IFC) control and thermal cycling functions in a single instrument. The key components are patented and designed to operate as an integrated system. It includes the Fluidigm proprietary multilayer soft lithography (MSL®) process and silicone Nanoflex™ valve technology, which enable high-quality and consistent IFC production and are all unique to Fluidigm. Fluidigm utilizes proprietary design and production processes for all genotyping, gene expression, digital PCR and NGS library preparation IFCs. Each IFC enables researchers to prepare and automate nanoliter-volume reactions with Juno.

C1™ is a unique and proprietary microfluidics system designed to isolate and prepare individual cells for genomic analysis applications. C1 is a fully integrated system that enables capture, staining for cell viability, imaging of cells for viability and phenotype, cell lysis and template preparation from up to 800 single cells, all on a single platform. The platform is comprised of the C1 system, which includes controller software for IFC loading, priming, and processing; the C1 IFC for cell capture and preparation; and C1 reagent kits containing reagents for cell suspension, lysis and harvest. The system is solely produced by Fluidigm, and the key components are patented and designed to operate as an integrated system. The C1 IFC is a proprietary integrated fluidic circuit that captures and prepares up to 800 individual cells in parallel and is the only IFC compatible with the C1 system. The IFC is based on Fluidigm multilayer soft lithography (MSL®) technology, a patented method that enables automatic and precise mixing of reagents into cell-independent, fixed, partitioned nanoliter reaction chambers, preventing sample mix-up or cross contamination. The C1 IFC requires as few as 200 cells for starting material, reduces reagent usage 200-fold and reagent costs by eight-fold, depending on the genomic application.

Publisher note: Precise information on deadline(s) for review procedures: The Authority will allow a minimum 10 calendar day standstill period between notifying the award decision and awarding the contract. Should additional information be required it should be requested from the addressee in section I.1. Aggrieved parties who have been harmed or are at risk of harm by breach of the procurement rules have the right to take action in the High Court (England and Wales). Any such action is subject to strict time limits in accordance with the Public Contracts (Amendments) Regulations 2015.

• Fluidigm UK LimitedAwarded supplier06612614 12 New Fetter Lane, London, UK, EC4A 1JP

No document links were published on the notice.